Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
Jonathan H. Schatz(Memorial Sloan Kettering Cancer Center), Hans‐Guido Wendel(Kettering University)
Cited by 114
Related Papers
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy
|The Journal of Experimental Medicine|2014|33
Noncovalent inhibitors reveal BTK gatekeeper and auto-inhibitory residues that control its transforming activity
|JCI Insight|2019|33
TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors
|Oncotarget|2016|22
A Rapid Translational Immune Response Program in CD8 Memory T Lymphocytes
|The Journal of Immunology|2022|12